An open-label cohort study of the improvement of quality of life and pain in de novo cervical dystonia patients after injections with 500 U botulinum toxin A (Dysport)
about
What is quality of life and how do we measure it? Relevance to Parkinson's disease and movement disorders.Factors affecting the health-related quality of life of patients with cervical dystonia and impact of treatment with abobotulinumtoxinA (Dysport): results from a randomised, double-blind, placebo-controlled study.An international survey of patients with cervical dystonia.Practical guidance for CD management involving treatment of botulinum toxin: a consensus statement.Impact of Neu-botulinumtoxinA on the Severity and Quality of Life of Cervical Dystonia Patients.Striving for more good days: patient perspectives on botulinum toxin for the treatment of cervical dystonia.Pain Relief in Cervical Dystonia with Botulinum Toxin Treatment.Therapeutic approach to pain in neurodegenerative diseases: current evidence and perspectives.Abobotulinum Toxin A in the Treatment of Chronic Low Back PainTreatment satisfaction with botulinum toxin: a comparison between blepharospasm and cervical dystonia.Neurocognitive outcomes in children with unilateral basal ganglia arterial ischemic stroke and secondary hemidystonia.Long-term quality of life in cervical dystonia after treatment with abobotulinum toxin A: a 2-year prospective study.
P2860
Q30240282-24A5211B-969A-404C-8D65-CBF0CCDE6859Q34364973-2E589CA8-7D14-4F0E-91E9-BED15A8EF821Q35981106-27A4CCCE-6CA5-469F-A92B-C64D6912A3C5Q36171693-C3EE5249-391D-4A36-BAD0-1539B80EC1F3Q37156224-15FCFF7B-FD96-46C9-814C-DDFBEB5238A4Q37211128-85C4A369-08B7-4778-BAE3-BADD98D6D4A5Q38537633-554005FF-CAD3-403F-9EE2-0196A8C8BC6AQ38892540-F954B5DD-E13A-45F0-81A9-21CF5A8B49F0Q39095007-20F6E20C-602D-491D-BA6B-F9388D4EAFF4Q42735621-19125BA5-B5CD-4D95-99B6-2B122474E765Q48199154-ACBB2AEC-E1D9-4C35-B6D2-C97B6A2F7FC4Q55100812-3153DF0B-49E0-455C-B5AC-688D7A63AD2F
P2860
An open-label cohort study of the improvement of quality of life and pain in de novo cervical dystonia patients after injections with 500 U botulinum toxin A (Dysport)
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
An open-label cohort study of ...... U botulinum toxin A (Dysport)
@ast
An open-label cohort study of ...... U botulinum toxin A (Dysport)
@en
type
label
An open-label cohort study of ...... U botulinum toxin A (Dysport)
@ast
An open-label cohort study of ...... U botulinum toxin A (Dysport)
@en
prefLabel
An open-label cohort study of ...... U botulinum toxin A (Dysport)
@ast
An open-label cohort study of ...... U botulinum toxin A (Dysport)
@en
P2093
P2860
P1433
P1476
An open-label cohort study of ...... U botulinum toxin A (Dysport)
@en
P2093
P2860
P356
10.1136/BMJOPEN-2012-001853
P577
2013-04-18T00:00:00Z